Bioblast Pharma reports second quarter 2016 financial results
Bioblast reported a net loss of $3.685 million for the 2016 second quarter versus a net loss of $3.686 million in the same 2015 quarter. The net loss for the first half of 2016 was $8.279 million versus $6.985 million for the first half of 2015. August 25, 2016